53,155€
-1,86%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co
Bid:
Ask:
Anlagetrends der Bristol-Myers Squibb Co Aktie
Krebs-Immuntherapie
Biotechnologiekonzern forscht und entwickelt u.a. an Krebsimmuntherapieansätzen
Bristol-Myers Squibb Co gehört zu den Prime Aktien im Anlagetrend Krebs-Immuntherapie
Sektor: Medizin / Pharmaunternehmen
| Abbott Laboratories | - | 94,71€ | -0,66 % | ||
| ABBVIE | 1 | 258,40€ | -0,84 % | ||
| Agile Therapeutics | - | 0,60$ | 11,52 % | ||
| Akorn Inc. | - | - | - | ||
| Alcon | - | 74,52$ | -0,98 % | ||
| ASTRAZENECA DL-,25 SP.ADR | 2 | 92,83$ | 0,26 % | ||
| AstraZeneca PLC | 2 | 159,80€ | -2,23 % | ||
| Baxter International | - | 23,14€ | -2,53 % | ||
| BAYER AG NA O.N. | 2 | 54,46€ | -2,65 % | ||
| BIOTEST AG VZ O.N. | - | 29,50€ | -0,67 % | ||
| Bristol-Myers Squibb Co | - | 53,16€ | -1,86 % | ||
| Cumberland Pharmaceuticals | - | 6,44$ | -1,98 % | ||
| DERMAPHARM HLDG INH O.N. | - | 33,43€ | -1,84 % | ||
| Eagle Pharmaceuticals | - | 1,92€ | -0,78 % | ||
| Eli Lilly & Co | 4 | 1.231,50€ | -2,12 % | ||
| Endo International PLC | - | 0,29€ | -6,77 % | ||
| GRIFOLS SA INH. A EO-,25 | - | 10,84€ | -5,98 % | ||
| GSK plc | - | 39,90€ | -1,72 % | ||
| GSK PLC LS-,25 | - | 16,77€ | -17,24 % | ||
| HEIDELBERG PHARMA AG O.N. | - | 2,05€ | -0,49 % | ||
| Johnson & Johnson | 1 | 243,45€ | -1,97 % | ||
| Lannett Co. Inc. | - | 0,58€ | -9,38 % | ||
| Merck & Co | 4 | 121,00€ | -3,60 % | ||
| Nature's Sunshine Products | - | 10,19$ | -1,26 % | ||
| Novartis AG | - | 137,50€ | -3,85 % | ||
| NOVARTIS NAM. SF 0,49 | - | 127,63CHF | -2,93 % | ||
| Novo-Nordisk A/S | - | 35,44€ | -1,45 % | ||
| Pfizer | - | 25,12€ | -1,67 % | ||
| ROCHE HLDG AG INH. SF 1 | 1 | 402,28CHF | -1,30 % | ||
| Rockwell Medical Inc | - | 6,26$ | 2,62 % | ||
| Sanofi ADS | - | 41,90€ | -3,46 % | ||
| SANOFI SA INHABER EO 2 | - | 83,67€ | -2,99 % | ||
| Taro Pharmaceutical Industries Ltd | - | 42,97$ | 0,00 % | ||
| TEVA PHARMACEUT. SP.ADR | - | 37,10$ | 2,06 % | ||
| ZOETIS | - | 73,64€ | -6,50 % | ||